110 related articles for article (PubMed ID: 22435555)
61. Transcriptional regulation of chemokine expression in ovarian cancer.
Singha B; Gatla HR; Vancurova I
Biomolecules; 2015 Mar; 5(1):223-43. PubMed ID: 25790431
[TBL] [Abstract][Full Text] [Related]
62. TNFα signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome.
Franco HL; Nagari A; Kraus WL
Mol Cell; 2015 Apr; 58(1):21-34. PubMed ID: 25752574
[TBL] [Abstract][Full Text] [Related]
63. TNFα signalling primes chromatin for NF-κB binding and induces rapid and widespread nucleosome repositioning.
Diermeier S; Kolovos P; Heizinger L; Schwartz U; Georgomanolis T; Zirkel A; Wedemann G; Grosveld F; Knoch TA; Merkl R; Cook PR; Längst G; Papantonis A
Genome Biol; 2014 Dec; 15(12):536. PubMed ID: 25608606
[TBL] [Abstract][Full Text] [Related]
64. IKK phosphorylates RelB to modulate its promoter specificity and promote fibroblast migration downstream of TNF receptors.
Authier H; Billot K; Derudder E; Bordereaux D; Rivière P; Rodrigues-Ferreira S; Nahmias C; Baud V
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14794-9. PubMed ID: 25267645
[TBL] [Abstract][Full Text] [Related]
65. Prolonged tumor necrosis factor α primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin.
Sohn C; Lee A; Qiao Y; Loupasakis K; Ivashkiv LB; Kalliolias GD
Arthritis Rheumatol; 2015 Jan; 67(1):86-95. PubMed ID: 25199798
[TBL] [Abstract][Full Text] [Related]
66. IRF5:RelA interaction targets inflammatory genes in macrophages.
Saliba DG; Heger A; Eames HL; Oikonomopoulos S; Teixeira A; Blazek K; Androulidaki A; Wong D; Goh FG; Weiss M; Byrne A; Pasparakis M; Ragoussis J; Udalova IA
Cell Rep; 2014 Sep; 8(5):1308-17. PubMed ID: 25159141
[TBL] [Abstract][Full Text] [Related]
67. Regulation of NF-κB by TNF family cytokines.
Hayden MS; Ghosh S
Semin Immunol; 2014 Jun; 26(3):253-66. PubMed ID: 24958609
[TBL] [Abstract][Full Text] [Related]
68. NF-κB and Rheumatoid Arthritis: Will Understanding Genetic Risk Lead to a Therapeutic Reward?
Scheinman R
For Immunopathol Dis Therap; 2013 Apr; 4(2):93-110. PubMed ID: 24678426
[TBL] [Abstract][Full Text] [Related]
69. Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-кB target genes in human breast cancer.
Dalmases A; González I; Menendez S; Arpí O; Corominas JM; Servitja S; Tusquets I; Chamizo C; Rincón R; Espinosa L; Bigas A; Eroles P; Furriol J; Lluch A; Rovira A; Albanell J; Rojo F
Oncotarget; 2014 Jan; 5(1):196-210. PubMed ID: 24344116
[TBL] [Abstract][Full Text] [Related]
70. Proteasome inhibition increases recruitment of IκB kinase β (IKKβ), S536P-p65, and transcription factor EGR1 to interleukin-8 (IL-8) promoter, resulting in increased IL-8 production in ovarian cancer cells.
Singha B; Gatla HR; Manna S; Chang TP; Sanacora S; Poltoratsky V; Vancura A; Vancurova I
J Biol Chem; 2014 Jan; 289(5):2687-700. PubMed ID: 24337575
[TBL] [Abstract][Full Text] [Related]
71. Chitosan oligosaccharides block LPS-induced O-GlcNAcylation of NF-κB and endothelial inflammatory response.
Li Y; Liu H; Xu QS; Du YG; Xu J
Carbohydr Polym; 2014 Jan; 99():568-78. PubMed ID: 24274545
[TBL] [Abstract][Full Text] [Related]
72. BCL-3 attenuation of TNFA expression involves an incoherent feed-forward loop regulated by chromatin structure.
Walker T; Adamson A; Jackson DA
PLoS One; 2013; 8(10):e77015. PubMed ID: 24130828
[TBL] [Abstract][Full Text] [Related]
73. Binding of NF-κB to nucleosomes: effect of translational positioning, nucleosome remodeling and linker histone H1.
Lone IN; Shukla MS; Charles Richard JL; Peshev ZY; Dimitrov S; Angelov D
PLoS Genet; 2013; 9(9):e1003830. PubMed ID: 24086160
[TBL] [Abstract][Full Text] [Related]
74. Distinct mechanisms for induction and tolerance regulate the immediate early genes encoding interleukin 1β and tumor necrosis factor α.
Adamik J; Wang KZ; Unlu S; Su AJ; Tannahill GM; Galson DL; O'Neill LA; Auron PE
PLoS One; 2013; 8(8):e70622. PubMed ID: 23936458
[TBL] [Abstract][Full Text] [Related]
75. Regulation and function of nuclear IκBα in inflammation and cancer.
Vancurova I; Vancura A
Am J Clin Exp Immunol; 2012; 1(1):56-66. PubMed ID: 23885315
[TBL] [Abstract][Full Text] [Related]
76. Celebrating 25 years of NF-κB research.
Ghosh S; Hayden MS
Immunol Rev; 2012 Mar; 246(1):5-13. PubMed ID: 22435544
[No Abstract] [Full Text] [Related]
77. NF-κB and chromatin: ten years on the path from basic mechanisms to candidate drugs.
Natoli G
Immunol Rev; 2012 Mar; 246(1):183-92. PubMed ID: 22435555
[TBL] [Abstract][Full Text] [Related]
78. Tuning up inflammation: how DNA sequence and chromatin organization control the induction of inflammatory genes by NF-kappaB.
Natoli G
FEBS Lett; 2006 May; 580(12):2843-9. PubMed ID: 16530189
[TBL] [Abstract][Full Text] [Related]
79. It takes two to tango: IκBs, the multifunctional partners of NF-κB.
Hinz M; Arslan SÇ; Scheidereit C
Immunol Rev; 2012 Mar; 246(1):59-76. PubMed ID: 22435547
[TBL] [Abstract][Full Text] [Related]
80. Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer.
Steger DJ; Workman JL
EMBO J; 1997 May; 16(9):2463-72. PubMed ID: 9171359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
